Reports

Sale

JE (Japanese Encephalitis) Vaccine Market

Global JE (Japanese Encephalitis) Vaccine Market Forecast: By Type: Inactivated, Recombinant, Live attenuated; By Distribution Channel: Hospitals, Retail, Online; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; 2024-2032

Global JE (Japanese Encephalitis) Vaccine Market Outlook

The global JE (Japanese encephalitis) vaccine market was estimated to value at USD 215.15 million in 2023. It is expected to grow at a CAGR of 5.5% during the forecast period of 2024-2032 to reach a value of USD 348.34 million in 2032.

 

The increasing mosquito nuisance, rising awareness, and the growing investment in the healthcare sector by the governments across the nations are some of the significant factors contributing to the growth of the global JE (Japanese encephalitis) vaccine market.

 

Global JE (Japanese Encephalitis) Vaccine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

Japanese encephalitis (JE) vaccine is an inactivated vaccine that provides protection against Japanese encephalitis, an infection of the brain caused by the Japanese encephalitis virus (JEV), generally spread by mosquitoes.

The global JE (Japanese encephalitis) vaccine industry can be broadly categorised based on segments like types, distribution channels, and regions.

  • Type:
    • Inactivated 
    • Recombinant 
    • Live attenuated 
  • Distribution Channel:
    • Hospitals
    • Retail 
    • Online 

The EMR report looks into the regional markets of global JE (Japanese encephalitis) vaccine market like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

 

Market Analysis

The increase in the prevalence and incidence of Japanese encephalitis disease is driving the demand for global JE (Japanese encephalitis) vaccines globally. With the growing trend of routine immunisation or vaccination, the industry is witnessing a strong demand for global JE (Japanese encephalitis) vaccines. Further, the inclusion of Japanese encephalitis vaccination in national immunisation programmes by the governments across the nation is expected to be one of the significant growth drivers for the industry over the forecast period. The growing investment in R&D of these vaccines is aiding the industry growth. Within the Asia Pacific, China and India are at high risk of Japanese encephalitis. Thus, the governments of these countries are carrying out mass vaccinations, providing a further impetus to the industry. However, the lack of awareness may hamper the industry growth over the forecast period.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global JE (Japanese encephalitis) vaccine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Valneva SE
  • Bharat Biotech International Limited
  • Sanofi 
  • Chengdu Institute of Biological Products Co., Ltd.
  • Others 

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Distribution Channel
  • Region
Breakup by Type
  • Inactivated
  • Recombinant
  • Live attenuated 
Breakup by Distribution Channel
  • Hospitals
  • Retail
  • Online
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Valneva SE
  • Sanofi
  • Bharat Biotech International Limited
  • Chengdu Institute of Biological Products Co. Ltd.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global JE (Japanese Encephalitis) Vaccine Market Analysis

    8.1    Key Industry Highlights
    8.2    Global JE (Japanese Encephalitis) Vaccine Historical Market (2018-2023) 
    8.3    Global JE (Japanese Encephalitis) Vaccine Market Forecast (2024-2032)
    8.4    Global JE (Japanese Encephalitis) Vaccine Market by Type
        8.4.1    Inactivated
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Recombinant 
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Live Attenuated 
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
    8.5    Global JE (Japanese Encephalitis) Vaccine Market by Distribution Channel
        8.5.1    Hospitals
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Retail 
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Online
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)   
    8.6    Global JE (Japanese Encephalitis) Vaccine Market by Region
        8.6.1    North America
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Europe
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Asia Pacific
            8.6.3.1    Historical Trend (2018-2023)
            8.6.3.2    Forecast Trend (2024-2032)
        8.6.4    Latin America
            8.6.4.1    Historical Trend (2018-2023)
            8.6.4.2    Forecast Trend (2024-2032)
        8.6.5    Middle East and Africa
            8.6.5.1    Historical Trend (2018-2023)
            8.6.5.2    Forecast Trend (2024-2032)
9    North America JE (Japanese Encephalitis) Vaccine Market Analysis
    9.1    United States of America
        9.1.1    Historical Trend (2018-2023)
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023)
        9.2.2    Forecast Trend (2024-2032)
10    Europe JE (Japanese Encephalitis) Vaccine Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023)
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific JE (Japanese Encephalitis) Vaccine Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023)
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America JE (Japanese Encephalitis) Vaccine Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023)
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa JE (Japanese Encephalitis) Vaccine Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023)
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Valneva SE
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Sanofi
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Bharat Biotech International Limited
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Chengdu Institute of Biological Products Co. Ltd.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Others
16    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global JE (Japanese Encephalitis) Vaccine Market: Key Industry Highlights, 2017 and 2027
2.    Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Type (USD Million), 2018-2023
3.    Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Type (USD Million), 2024-2032
4.    Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
5.    Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
6.    Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Region (USD Million), 2018-2023
7.    Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Region (USD Million), 2024-2032
8.    North America JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
9.    North America JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
10.    Europe JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
11.    Europe JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Asia Pacific JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
13.    Asia Pacific JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Latin America JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Latin America JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Middle East and Africa JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
17.    Middle East and Africa JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Global JE (Japanese Encephalitis) Vaccine Market Structure

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 5.5% between 2024 and 2032.

The major drivers of the market, such as a rise in incidences of Japanese encephalitis disease, increasing health awareness, rising demand from the developing regions, increased government investments in the medical sector, and the growing technological advancements, are expected to aid the market growth.

The key market trends guiding the growth of the market include the growing R&D activities, growing demand for routine immunisation, and initiation of national immunisation programmes by the governments across several nations.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Inactivated, recombinant, and live attenuated vaccines are the major types of the product in the market.

The leading distribution channels in the market include hospitals, retail, and online.

The major players in the market are Valneva SE, Sanofi, Bharat Biotech International Limited, Chengdu Institute of Biological Products Co. Ltd., among others.

Analyst Review

The global JE (Japanese encephalitis) vaccine market was estimated to value at USD 215.15 million in 2023. It is expected to grow at a CAGR of 5.5% during the forecast period of 2024-2032 to reach a value of USD 348.34 million in 2032. The market is being driven by the rising prevalence of Japanese encephalitis due to increasing mosquito nuisance. Aided by the growing knowledge of routine immunisation and favourable government initiatives, the market is expected to witness a growth during the forecast period.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its type, the market can be segmented into inactivated, recombinant, and live attenuated vaccines. On the basis of distribution channel, the market is divided into hospitals, retail, and online. The major regional markets for global JE (Japanese encephalitis) vaccine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Valneva SE, Sanofi, Bharat Biotech International Limited, Chengdu Institute of Biological Products Co. Ltd., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER